您好,欢迎来到试剂仪器网! [登录] [免费注册]
试剂仪器网
位置:首页 > 产品库 > Epinastine-13C-d3(hydrobromide)
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Epinastine-13C-d3(hydrobromide)
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Epinastine-13C-d3(hydrobromide)图片
包装:1mg
规格:98%
市场价:5319元
分子量:334.2

产品介绍
A neuropeptide with diverse biological activities
货号:ajcx22430
CAS:N/A
分子式:C15[13C]H12D3N3.HBr
分子量:334.2
溶解度:DMSO: soluble,Water: soluble
纯度:98%
存储:Store at -20°C
库存:现货

Background:

Epinastine-13C-d3is intended for use as an internal standard for the quantification of epinastine by GC- or LC-MS. Epinastine is a histamine H1receptor antagonist (Kiapps = 1.41 and 1.62 nM using guinea pig cerebellar and lung membranes, respectively) and mast cell stabilizer.1,2It inhibits IgE-induced histamine, TNF-α, and IL-10 secretion in human cord blood stem cell-derived mast cells (CBMCs) when used at a concentration of 0.1 μg/ml.2Epinastine inhibits histamine-induced cutaneous vascular permeability in rats and bronchoconstriction in anesthetized guinea pigs (ID50s = 5 and 0.1 mg/kg, respectively).3It inhibits dye leakage into the conjunctiva in a rat model of passive anaphylaxis reaction-induced vascular hyperpermeability of the conjunctiva (ID50= 9.7 mg/kg, p.o.).4Topical administration of formulations containing epinastine (0.05% three times per day) reduces lid edema, tearing, and redness, as well as the number of neutrophils and eosinophils in the lid fornix, in a mouse model of atopic conjunctivitis.2Formulations containing epinastine have been used in the prevention of itching associated with allergic conjunctivitis.


1.Ter Laak, A.M., DonnÉ-Op den Kelder, G.M., Bast, A., et al.Is there a difference in the affinity of histamine H1 receptor antagonists for CNS and peripheral receptors• An in vitro studyEur. J. Pharmacol.232(2-3)199-205(1993) 2.Galatowicz, G., Ajayi, Y., Stern, M.E., et al.Ocular anti-allergic compounds selectively inhibit human mast cell cytokines in vitro and conjunctival cell infiltration in vivoClin. Exp. Allergy37(11)1648-1656(2007) 3.Matsushita, K., Nobutoshi, A., and Aritake, K.Pharmacological studies on the novel antiallergic drug HQL-79: II. Elucidation of mechanisms for antiallergic and antiasthmatic effectsJpn. J. Pharmacol.78(1)11-22(1998) 4.Tamura, T., Sato, H., Miki, I., et al.Effects of orally administered olopatadine hydrochloride on the ocular allergic reaction in ratsAllergol. Int.52(2)77-83(2003)